ATE480625T1 - Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion - Google Patents

Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion

Info

Publication number
ATE480625T1
ATE480625T1 AT07101045T AT07101045T ATE480625T1 AT E480625 T1 ATE480625 T1 AT E480625T1 AT 07101045 T AT07101045 T AT 07101045T AT 07101045 T AT07101045 T AT 07101045T AT E480625 T1 ATE480625 T1 AT E480625T1
Authority
AT
Austria
Prior art keywords
chlamydia pneumoniae
polypeptides
infection
prevention
relates
Prior art date
Application number
AT07101045T
Other languages
English (en)
Inventor
Remy Griffais
Susan K Hoiseth
Robert John Zagursky
Benjamin J Metcalf
Joel A Peek
Banumathi Sankaran
Leah Diane Fletcher
Original Assignee
Merck Serono Biodevelopment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Biodevelopment filed Critical Merck Serono Biodevelopment
Application granted granted Critical
Publication of ATE480625T1 publication Critical patent/ATE480625T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07101045T 1997-11-21 1998-11-20 Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion ATE480625T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714673 1997-11-21
US10707898P 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
ATE480625T1 true ATE480625T1 (de) 2010-09-15

Family

ID=9513667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07101045T ATE480625T1 (de) 1997-11-21 1998-11-20 Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion

Country Status (6)

Country Link
US (4) US6559294B1 (de)
AT (1) ATE480625T1 (de)
CY (1) CY1106408T1 (de)
DE (1) DE69841894D1 (de)
ES (1) ES2352082T3 (de)
PT (1) PT1032674E (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JPH10502366A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクター・ピロリ抗原タンパク質調製品およびイムノアッセイ
GB2324093A (en) * 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
US6908770B1 (en) * 1998-07-16 2005-06-21 Board Of Regents, The University Of Texas System Fluid based analysis of multiple analytes by a sensor array
CA2353107A1 (en) 1998-12-01 2000-06-08 Andrew D. Murdin Chlamydia antigens and corresponding dna fragments and uses thereof
EP1169465B1 (de) * 1998-12-04 2006-03-01 University Of Manitoba Zwei-schritte-verfahren zur impfung gegen chlamydia
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US7297341B1 (en) * 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2354431A1 (en) * 1998-12-23 2000-07-06 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US6808713B1 (en) * 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
MXPA01009256A (es) * 1999-03-12 2003-07-14 Aventis Pasteur Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
DE60036698T2 (de) * 1999-05-03 2008-07-24 Sanofi Pasteur Ltd., Toronto Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
NZ517952A (en) * 1999-09-20 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
DE60040835D1 (de) * 1999-09-21 2009-01-02 Japan Tobacco Inc Neues protein, gen das dieses kodiert und verfahren zu dessen verwendung
AU1375501A (en) * 1999-11-12 2001-05-30 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1240331B1 (de) * 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
US20020071831A1 (en) * 2000-04-04 2002-06-13 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020082402A1 (en) * 2000-04-04 2002-06-27 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20040254130A1 (en) * 2000-05-08 2004-12-16 Murdin Andrew D Chlamydia antigens and corresponding dna fragments and uses thereof
DE60132221T2 (de) * 2000-05-23 2009-01-02 Baxter Healthcare S.A., Wallisellen Reagenzien zur zellselektion und verfahren zur anwendung
JP2004502415A (ja) * 2000-07-03 2004-01-29 カイロン　エセ．ピー．アー． Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅに対する免疫化
US7811592B2 (en) * 2000-08-16 2010-10-12 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
KR20030069989A (ko) * 2000-09-08 2003-08-27 다이이찌 산토리 파마 가부시키가이샤 심부전 치료제
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US7537772B1 (en) 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
WO2002048185A2 (en) * 2000-12-14 2002-06-20 Institut Pasteur Method for identifying secreted chlamydia polypeptides by using a type iii secretion system of a gram-negative
US20070149474A1 (en) * 2000-12-15 2007-06-28 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
US8206724B2 (en) * 2000-12-15 2012-06-26 Auburn University Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
US20030059896A1 (en) * 2000-12-21 2003-03-27 Shire Biochem Inc. Novel chlamydia antigens and corresponding DNA fragments
EP1383922A4 (de) * 2001-04-10 2005-03-30 Agensys Inc Nukleinsäure und zugehöriges, für die behandlung und den nachweis von krebs geeignetes protein mit der bezeichnung 158p3d2
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
US20080112965A1 (en) * 2001-10-01 2008-05-15 Aventis Pasteur Limited Chlamydia OMP antigen
US7461046B2 (en) * 2002-02-07 2008-12-02 The University Of Utah Research Foundation Method for creating and using a treatment protocol
US8257967B2 (en) * 2002-04-26 2012-09-04 Board Of Regents, The University Of Texas System Method and system for the detection of cardiac risk factors
BR0316465A (pt) * 2002-11-22 2005-10-11 Wyeth Corp Composição para o tratamento de infecções por chlamydia e métodos para indentificar as mesmas
US20070003568A1 (en) * 2003-02-24 2007-01-04 Alice Dautry-Varsat Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
WO2004113374A2 (en) * 2003-06-17 2004-12-29 Intercell Ag Chlamydia pneumoniae antigens
WO2005020785A2 (en) * 2003-07-15 2005-03-10 The Regents Of The University Of California Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
US8101431B2 (en) 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
ES2655833T3 (es) * 2004-05-11 2018-02-21 AbGenomics Coöperatief U.A. Epítopos que inducen la muerte de células T
US20060253097A1 (en) * 2004-10-21 2006-11-09 Braig James R Methods of treating diabetes
ATE490342T1 (de) * 2005-02-07 2010-12-15 Gen Probe Inc Zusammensetzungen und verfahren zum nachweis von streptokokken der gruppe b
WO2007053186A2 (en) 2005-05-31 2007-05-10 Labnow, Inc. Methods and compositions related to determination and use of white blood cell counts
WO2006133385A2 (en) * 2005-06-06 2006-12-14 Gen-Probe Incorporated Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample
EP1905825A1 (de) * 2006-09-29 2008-04-02 greenovation Biotech GmbH Galactosyltransferase
US20080160027A1 (en) * 2006-12-04 2008-07-03 Kathryn Frances Sykes Chlamydia pneumoniae vaccine and methods for administering such a vaccine
US20090092969A1 (en) * 2007-10-09 2009-04-09 Michael Aye Detection of atypical pneumonia
WO2011041788A2 (en) * 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Turkey viral hepatitis virus and uses thereof
CN102822352B (zh) * 2010-03-31 2015-07-29 有限会社山口技术特许机构 利用核酸色谱法的肺炎病原菌的检出方法
KR101311886B1 (ko) 2010-05-26 2013-09-26 한국기초과학지원연구원 폐렴연쇄상구균의 분비단백질을 포함하는 폐렴 진단용 조성물
CA2815046C (en) * 2010-10-19 2019-05-14 Mayo Foundation For Medical Education And Research Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
EP3604339B1 (de) 2011-01-14 2021-03-10 The Regents Of The University Of California Therapeutische antikörper gegen das ror-1-protein und verfahren zur verwendung davon
WO2014151011A1 (en) * 2013-03-15 2014-09-25 Georgetown University Selective inhibitor of angiotensin ii
CA2973220A1 (en) 2014-01-16 2015-07-23 Mcmaster University Type iii secretion injectisome proteins for treatment and prevention of chlamydial infections
CN114137209B (zh) * 2021-02-01 2024-03-01 中国水产科学研究院黄海水产研究所 一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69535914D1 (de) 1994-09-20 2009-03-26 Hitachi Chemical Co Ltd Polynukleotide die einen antigenes polypeptid aus chlamydia pneumoniae kodieren
US6493591B1 (en) * 2000-07-19 2002-12-10 Medtronic, Inc. Implantable active fixation lead with guidewire tip

Also Published As

Publication number Publication date
PT1032674E (pt) 2007-03-30
US20070053927A1 (en) 2007-03-08
DE69841894D1 (de) 2010-10-21
US20090274701A1 (en) 2009-11-05
US7101963B2 (en) 2006-09-05
US20040006218A1 (en) 2004-01-08
CY1106408T1 (el) 2011-10-12
US6559294B1 (en) 2003-05-06
ES2352082T3 (es) 2011-02-15
US7601531B2 (en) 2009-10-13

Similar Documents

Publication Publication Date Title
ATE480625T1 (de) Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion
DK1032674T3 (da) Chlamydia pneumoniae genomisk sekvens og polypeptider, fragmenter deraf og anvendelser deraf, især til diagnosen, forebyggelsen og behandlingen af infektion
WO1999028475A3 (en) Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
DE3588239T3 (de) Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren
WO2003008615A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced succ or sucd gene
WO2003004675A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
WO2003008602A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene
RU2673733C2 (ru) Способ амплификации днк на основе внедрения в цепь
DE69534747D1 (de) Haemophilus influenzae (nt hi) lkp tip adhesin protein und nukleinsäure
US6391631B1 (en) Bacterial plasmids
WO2002024904A2 (de) Verfahren zur herstellung von ribonukleinsäure (rns)
AU2002342763A1 (en) Process for the preparation of non-aromatic l-amino acids using strains of the enterobacteriaceae family
WO2003076636A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
Ikehara Possible Application of Entirely New Gene/Protein to Clinical Research
JP2008092948A (ja) 検体中の標的核酸を検出するためのキットおよび方法
ATE321862T1 (de) Coryneforme bakterien transformiert mit dem pknd- gen kodierenden nukleotidsequenzen und deren verwendung zur herstellung von l -aminosäuren
WO2003076629A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
MCKEE Primers are used at 20 pmol final concentration Target DNA is not generally isolated, cells are added to the reaction with or without a boiling (5 min) step
DE19935088A1 (de) DNA-Sequenzen, die sich zum spezifischen Nachweis von Pseudomonas putida KT2440 eignen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties